Moody's might lower AmSurg

Moody's Investors Service said it placed the Ba3 corporate family rating and Ba3-PD probability of default rating of AmSurg Corp. under review for downgrade following the company's May 29 announcement that it entered into an agreement to acquire Sheridan Holdings, Inc. in a transaction valued at $2.35 billion.

Moody's review will focus on the expected performance of the combined entities, the proposed capital structure and strategy for deleveraging, the timing and magnitude of synergies realized, as well as the combined organization's free cash flow capabilities and liquidity.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.